Publications

Gene expression profiles of similarly derived human embryonic stem cell lines correlate with their distinct propensity to exit stemness and their different differentiation behavior in culture

Sterthaus O, Feutz AC, Zhang H, Pletscher F, Bruder E, Miny P, Lezzi G, De Geyter M, De Geyter C

Cellular Reprogramming,  30 Jun 2014


Epigenetics and transmission

Paoloni-Giacobino A

Revue Médicale Suisse,  21 Mai 2014


Polymersomes containing quantum dots for cellular imaging

Camblin M, Detampel P, Kettiger H, Wu D, Balasubramanian V, Huwyler J

International Journal of Nanomedicine,  12 Mai 2014


International Consensus on drug allergy

Demoly P, Adkinson NF,, Brockow K, Castells M, Chiriac AM, Greenberger PA, Khan DA, Lang DM, Park HS, Pichler W, Sanchez-Borges M, Shiohara T, Thong BY

Allergy,  30 Apr 2014


Activation of Nrf2 in keratinocytes causes chloracne (MADISH)-like skin disease in mice

Schäfer M, Willrodt AH, Kurinna S, Link AS, Farwanah H, Geusau A, Gruber F, Sorg O, Huebner AJ, Roop DR, Sandhoff K, Saurat JH, Tschachler E, Schneider MR, Langbein L, Bloch W, Beer HD, Werner S

EMBO Molecular Medicine,  30 Apr 2014


Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responses

Adam J, Wuillemin N, Watkins S, Jamin H, Eriksson KK, Villiger P, Fontana S, Pichler WJ, Yerly D

PLoS One,  21 Apr 2014


Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01

Yun J, Marcaida MJ, Eriksson KK, Jamin H, Fontana S, Pichler WJ, Yerly D

Journal of Immunology,  1 Apr 2014


Acute cocaine-related health problems in patients presenting to an urban emergency department in Switzerland: a case series

Bodmer M, Enzler F, Liakoni E, Bruggisser M, Liechti ME

BMC Research Notes,  25 Mär 2014


Systems Toxicology: From Basic Research to Risk Assessment

Sturla SJ, Boobis AR, FitzGerald RE, Hoeng J, Kavlock RJ, Schirmer K, Whelan M, Wilks MF, Peitsch MC.

Chemical Research in Toxicology,  17 Mär 2014


Predictive value of CYP3A and ABCB1 phenotyping probes for the pharmacokinetics of sunitinib: the Clearsun study

Kloth JS, Klümpen HJ, Yu H, Eechoute K, Samer CF, Kam BL, Huitema AD, Daali Y, Zwinderman AH, Balakrishnar B, Bennink RJ, Wong M, Schellens JH, Mathijssen RH, Gurney H

Clinical Pharmacokinetics,  1 Mär 2014